Table 3.
Standard | Clinicians | Pharmacists | ||
---|---|---|---|---|
n | Weighted % | n | Weighted % | |
Standards implemented for any vaccine | ||||
Assess | 1,657 | 97.0 | 253 | 97.4 |
Recommend | 1,620 | 94.7 | 227 | 87.3 |
Administer | 1,392 | 83.5 | 243 | 93.3 |
Refer | 1,397 | 79.7 | 180 | 70.0 |
Document | 804 | 53.4 | 98 | 53.2 |
Assess for specific vaccines | ||||
Influenza | 1,589 | 93.5 | 243 | 93.9 |
PCV13 | 1,118 | 69.1 | 220 | 83.9 |
PPSV23 | 1,161 | 72.2 | 222 | 85.1 |
Zoster | 1,153 | 70.4 | 226 | 88.0 |
Tdap | 1,294 | 78.5 | 156 | 61.8 |
Td | 1,063 | 65.2 | 74 | 28.9 |
HPV | 1,054 | 62.8 | 50 | 19.4 |
Hepatitis B | 1,146 | 69.1 | 88 | 34.7 |
Recommend specific vaccines | ||||
Influenza | 1,591 | 93.3 | 226 | 86.7 |
PCV13 | 1,155 | 70.5 | 209 | 80.4 |
PPSV23 | 1,225 | 75.2 | 212 | 81.0 |
Zoster | 1,309 | 79.0 | 223 | 85.9 |
Tdap | 1,337 | 80.9 | 183 | 72.5 |
Td | 1,023 | 62.4 | 109 | 43.1 |
HPV | 1,163 | 69.8 | 97 | 38.7 |
Hepatitis B | 1,219 | 73.7 | 121 | 48.0 |
Stock specific vaccines | ||||
Influenza | 1,329 | 80.3 | 241 | 92.6 |
PCV13 | 809 | 51.8 | 230 | 88.8 |
PPSV23 | 852 | 54.4 | 231 | 88.8 |
Zoster | 620 | 38.7 | 238 | 91.6 |
Tdap | 1,091 | 66.7 | 206 | 78.2 |
Td | 789 | 50.7 | 74 | 29.0 |
HPV | 881 | 54.3 | 91 | 35.3 |
Hepatitis B | 844 | 54.4 | 136 | 51.4 |
Refer adults for specific vaccines | ||||
Influenza | 587 | 31.1 | 46 | 17.1 |
PCV13 | 680 | 37.5 | 41 | 16.6 |
PPSV23 | 694 | 37.5 | 44 | 17.6 |
Zoster | 985 | 56.5 | 41 | 15.9 |
Tdap | 564 | 31.5 | 173 | 64.8 |
Td | 533 | 28.7 | 87 | 35.2 |
HPV | 604 | 33.1 | 113 | 45.7 |
Hepatitis B | 687 | 37.9 | 93 | 38.6 |
Places referred for vaccination | ||||
Health department | 867 | 50.5 | 115 | 45.9 |
Pharmacy/another pharmacy | 971 | 56.1 | 76 | 30.0 |
Another HCP/medical provider | 719 | 36.4 | 134 | 53.7 |
Travel clinic | 590 | 36.5 | 60 | 22.2 |
Outpatient clinic within pharmacy | N/A | N/A | 42 | 17.6 |
Other | 26 | 1.2 | 2 | 0.6 |
Note: Respondents who reported “unsure” were excluded.
Clinicians include physicians, nurse practitioners, and physician assistants. Data for clinicians were obtained from the 2017 National Survey of Healthcare Providers Regarding Vaccination Practices for Adults, conducted for the Centers for Disease Control and Prevention by Abt Associates.
Data for pharmacists were obtained from the 2017 National Survey of Pharmacists Regarding Vaccination Practices for Adults, conducted for the Centers for Disease Control and Prevention by Abt Associates.
HCP, healthcare provider; hepatitis B, hepatitis B vaccine; influenza, seasonal influenza vaccine; HPV, human papillomavirus vaccine; N/A, not applicable; PCV13, 13-valent pneumococcal conjugate vaccine; PPSV23, 23-valent pneumococcal polysaccharide vaccine; Td, tetanus and diphtheria toxoids; Tdap, tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis; zoster, herpes zoster vaccine.